A drug for preventing and treating senile dementia

Abstract

The invention discloses a medicament for preventing and treating alzheimer disease. The medicament is prepared from the following raw materials: acai berry, hirudin, red-rooted salvia root, Chinese yam, dried tangerine or orange peel, the root bark of the peony tree, fructus alpiniae oxyphyllae, Chinese magnoliavine fruit, pseudo-ginseng, safflower, orange, radix tinosporae, American ginseng and liquorice. According to the medicament, key pathological links of brain insufficiency and phlegm stagnation and aperture blockage of the alzheimer disease are reasonably applied and hit, a pathological process of the alzheimer disease is possibly blocked, the dysfunction is improved, the theory of causing alzheimer disease by deficiency of the kidney and the theory of storing essence by the kidney in the traditional Chinese medicine are fully developed, the theory of growing marrow and dredging brain guides the function of clinical practice, and thus the purposes of treatment and protection are achieved.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for preventing and treating senile dementia. Background technique [0002] Senile dementia is a degeneration of the nervous system, characterized by senile plaques, neurofibrillary tangles, vacuolar degeneration of pyramidal cells in the hippocampus and neuron loss. Clinical onset is insidious, progressive mental decline, often accompanied by personality changes. The general symptoms continue to progress, and the course of the disease is usually 5-10 years, so it should be treated early. However, the treatment of its early memory impairment is a difficult clinical problem. Currently, the main drugs used are cholinergic preparations and non-cholinergic preparations. The most widely used is huperzine A. However, in recent years, it has been recognized that the efficacy of cholinesterase inhibitors depends on the integrity of cholinergic neurons. As the disease progre...

AI Technical Summary

Problems solved by technology

However, there are still many problems to be solved in order to be truly applied to the prevention and treatment of human senile dementia; as far as cell gene therapy is concerned, due to the lack of control over the persistence and stability of exogenous cells or gene expression, limitations its application in clinical practice

In addition, due to the long application cycle of current drug therapy, high cost, and many side effects, its clinical application has little effect, especially for severe dementia that is not discovered in time.

At present, in the treatment of Chinese patent medicines, the curative effects are mostly uncertain, and most of them are not specific, and there are no new Chinese medicines with certain curative effects that specifically treat this disease.

Images